Additional studies on C5L2, the only known receptor for ASP, are needed to better understand ASP-C5L2 signal transduction and to assess the potential of C5L2 as a pharmaceutical target in obesity and metabolic syndrome. This evidence concerns the gene C3 and obesity due to melanocortin 4 receptor deficiency.